Prediction of Human Papillomavirus Status and Overall Survival in Patients with Untreated Oropharyngeal Squamous Cell Carcinoma: Development and Validation of CT-Based Radiomics

References

1. 1.↵
   1. Pytynia KB,
   2. Dahlstrom KR,
   3. Sturgis EM

   . Epidemiology of HPV-associated oropharyngeal cancer. Oral Oncol 2014;50:380–86 doi:10.1016/j.oraloncology.2013.12.019 pmid:24461628

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Ang KK,
   2. Harris J,
   3. Wheeler R, et al

   . Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010;363:24–35 doi:10.1056/NEJMoa0912217 pmid:20530316

   CrossRefPubMedWeb of Science
3. 3.↵
   1. Chaturvedi AK,
   2. Engels EA,
   3. Pfeiffer RM, et al

   . Human papillomavirus and rising oropharyngeal cancer incidence in the United States. JCO 2011;29:4294–4301 doi:10.1200/JCO.2011.36.4596 pmid:21969503

   Abstract/FREE Full Text
4. 4.↵
   1. Ragin CC,
   2. Taioli E

   . Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis. Int J Cancer 2007;121:1813–20 doi:10.1002/ijc.22851 pmid:17546592

   CrossRefPubMedWeb of Science
5. 5.↵
   1. O'Sullivan B,
   2. Huang SH,
   3. Siu LL, et al

   . Deintensification candidate subgroups in human papillomavirus–related oropharyngeal cancer according to minimal risk of distant metastasis. J Clin Oncol 2013;31:543–50 doi:10.1200/JCO.2012.44.0164 pmid:23295795

   Abstract/FREE Full Text
6. 6.↵
   1. Huang SH,
   2. Xu W,
   3. Waldron J, et al

   . Refining American Joint Committee on Cancer/Union for International Cancer Control TNM stage and prognostic groups for human papillomavirus-related oropharyngeal carcinomas. J Clin Oncol 2015;33:836–45 doi:10.1200/JCO.2014.58.6412 pmid:25667292

   Abstract/FREE Full Text
7. 7.↵
   1. O'Sullivan B,
   2. Huang SH,
   3. Su J, et al

   . Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal Cancer Network for Staging (ICON-S): a multicentre cohort study. Lancet Oncol 2016;17:440–51 doi:10.1016/S1470-2045(15)00560-4 pmid:26936027

   CrossRefPubMed
8. 8.↵
   1. Gillies RJ,
   2. Kinahan PE,
   3. Hricak H

   . Radiomics: images are more than pictures: they are data. Radiology 2016;278:563–77 doi:10.1148/radiol.2015151169 pmid:26579733

   CrossRefPubMed
9. 9.↵
   1. Ravanelli M,
   2. Grammatica A,
   3. Tononcelli E, et al

   . Correlation between human papillomavirus status and quantitative MR imaging parameters including diffusion-weighted imaging and texture features in oropharyngeal carcinoma. AJNR Am J Neuroradiol 2018;39:1878–83 doi:10.3174/ajnr.A5792 pmid:30213805

   Abstract/FREE Full Text
10. 10.↵
    1. Driessen JP,
    2. Caldas-Magalhaes J,
    3. Janssen LM, et al

    . Diffusion-weighted MR imaging in laryngeal and hypopharyngeal carcinoma: association between apparent diffusion coefficient and histologic findings. Radiology 2014;272:456–63 doi:10.1148/radiol.14131173 pmid:24749712

    CrossRefPubMed
11. 11.↵
    1. Westra WH

    . The morphologic profile of HPV-related head and neck squamous carcinoma: implications for diagnosis, prognosis, and clinical management. Head Neck Pathol 2012;6(Supple 1):48–54 doi:10.1007/s12105-012-0371-6 pmid:22782223

    CrossRefPubMed
12. 12.↵
    1. Leijenaar RT,
    2. Carvalho S,
    3. Hoebers FJ, et al

    . External validation of a prognostic CT-based radiomic signature in oropharyngeal squamous cell carcinoma. Acta Oncol 2015;54:1423–29 doi:10.3109/0284186X.2015.1061214 pmid:26264429

    CrossRefPubMed
13. 13.↵
    1. Ou D,
    2. Blanchard P,
    3. Rosellini S, et al

    . Predictive and prognostic value of CT based radiomics signature in locally advanced head and neck cancers patients treated with concurrent chemoradiotherapy or bioradiotherapy and its added value to human papillomavirus status. Oral Oncol 2017;71:150–55 doi:10.1016/j.oraloncology.2017.06.015 pmid:28688683

    CrossRefPubMed
14. 14.↵
    1. Bogowicz M,
    2. Riesterer O,
    3. Ikenberg K, et al

    . Computed tomography radiomics predicts HPV status and local tumor control after definitive radiochemotherapy in head and neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2017;99:921–98 doi:10.1016/j.ijrobp.2017.06.002 pmid:28807534

    CrossRefPubMed
15. 15.↵
    1. Ren J,
    2. Tian J,
    3. Yuan Y, et al

    . Magnetic resonance imaging based radiomics signature for the preoperative discrimination of stage I-II and III-IV head and neck squamous cell carcinoma. Eur J Radiol 2018;106:1–6 doi:10.1016/j.ejrad.2018.07.002 pmid:30150029

    CrossRefPubMed
16. 16.↵
    1. Aerts HJ,
    2. Velazquez ER,
    3. Leijenaar RT, et al

    . Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun 2014;5:4006 doi:10.1038/ncomms5006 pmid:24892406

    CrossRefPubMed
17. 17.↵
    1. Moltz JH,
    2. Bornemann L,
    3. Kuhnigk J-M, et al

    . Advanced segmentation techniques for lung nodules, liver metastases, and enlarged lymph nodes in CT scans. IEEE J Sel Top Signal Process 2009;3:122–34 doi:10.1109/JSTSP.2008.2011107

    CrossRef
18. 18.↵
    1. van Griethuysen JJ,
    2. Fedorov A,
    3. Parmar C, et al

    . Computational radiomics system to decode the radiographic phenotype. Cancer Res 2017;77:e104–07 doi:10.1158/0008-5472.CAN-17-0339 pmid:29092951

    Abstract/FREE Full Text
19. 19.↵
    1. Kursa MB,
    2. Rudnicki WR

    . Feature selection with the Boruta package. J Stat Softw 2010;36:1–13 doi:10.18637/jss.v036.i11

    CrossRefPubMed
20. 20.↵
    1. Sauerbrei W,
    2. Royston P,
    3. Binder H

    . Selection of important variables and determination of functional form for continuous predictors in multivariable model building. Statist Med 2007;26:5512–28 doi:10.1002/sim.3148 pmid:18058845

    CrossRefPubMedWeb of Science
21. 21.↵
    1. Huang C,
    2. Cintra M,
    3. Brennan K, et al

    . Development and validation of radiomic signatures of head and neck squamous cell carcinoma molecular features and subtypes. EBioMedicine 2019;45:70–80 doi:10.1016/j.ebiom.2019.06.034 pmid:31255659

    CrossRefPubMed
22. 22.↵
    1. Apostolova I,
    2. Steffen IG,
    3. Wedel F, et al

    . Asphericity of pretherapeutic tumour FDG uptake provides independent prognostic value in head-and-neck cancer. Eur Radiol 2014;24:2077–87 doi:10.1007/s00330-014-3269-8 pmid:24965509

    CrossRefPubMed
23. 23.↵
    1. Buch K,
    2. Fujita A,
    3. Li B, et al

    . Using texture analysis to determine human papillomavirus status of oropharyngeal squamous cell carcinomas on CT. AJNR Am J Neuroradiol 2015;36:1343–48 doi:10.3174/ajnr.A4285 pmid:25836725

    Abstract/FREE Full Text
24. 24.↵
    1. Fujita A,
    2. Buch K,
    3. Li B, et al

    . Difference between HPV-positive and HPV-negative non-oropharyngeal head and neck cancer: texture analysis features on CT. J Compu Assist Tomogr 2016;40:43–47 doi:10.1097/RCT.0000000000000320 pmid:26466116

    CrossRefPubMed
25. 25.↵
    1. Traverso A,
    2. Wee L,
    3. Dekker A, et al

    . Repeatability and reproducibility of radiomic features: a systematic review. Int J Radiat Oncol Biol Phys 2018;102:1143–58 doi:10.1016/j.ijrobp.2018.05.053 pmid:30170872

    CrossRefPubMed